Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli

A series of new plasmid expression vectors (the pTrc series) has been constructed for the regulated expression of genes in Escherichia coli. Based on pKK233-2 [Amann and Brosius, Gene 40 (1985) 183–190], the vectors carry a strong hybrid trp/lac promoter, the lacZribosome-binding site (RBS), the mul...

Full description

Saved in:
Bibliographic Details
Published inGene Vol. 69; no. 2; pp. 301 - 315
Main Authors Amann, Egon, Ochs, Birgit, Abel, Karl-Josef
Format Journal Article
LanguageEnglish
Published Lausanne Elsevier B.V 30.09.1988
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of new plasmid expression vectors (the pTrc series) has been constructed for the regulated expression of genes in Escherichia coli. Based on pKK233-2 [Amann and Brosius, Gene 40 (1985) 183–190], the vectors carry a strong hybrid trp/lac promoter, the lacZribosome-binding site (RBS), the multiple cloning site of pUC18 and the rrnB transcription terminators. With the aid of synthetic oligodeoxynucleotides, the multiple cloning site has been inserted behind an NcoI site in three reading frames. Thus, the vectors are equally useful for the expression of proteins in their authentic, non-fused form (by using the NcoI site) and for the expression of fusion proteins (by choosing any of the cloning sites in the correct translational frame). To ensure complete repression of the hybrid trp/lac promoter during construction and growth in any host strain, the lacI q allele of the lac repressor gene was added to some of the vectors. The complete vector nucleotide sequence and examples of heterologous gene expression (human coagulation factor XIIIa and human placental anticoagulant protein PP4) with the new vectors are presented.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0378-1119
1879-0038
DOI:10.1016/0378-1119(88)90440-4